BioAtla, Inc. — Investor Relations & Filings
BioAtla, Inc. is a clinical-stage biopharmaceutical company that develops novel antibody-based therapeutics for the treatment of solid tumor cancers. The company's core focus is its proprietary Conditionally Active Biologics™ (CAB) platform. This technology is engineered to create protein therapeutics, including monoclonal antibodies, that are activated specifically within the physiological conditions of the tumor microenvironment. The primary goal of this approach is to enhance the therapeutic index of its drugs, making them safer and more effective by concentrating their activity on cancerous cells while minimizing damage to healthy tissue.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2025 | 2025-01-24 | English | |
| 424B5 | 2024-12-20 | English | |
| 8-K | 2024-12-20 | English | |
| 8-K | 2024-12-20 | English | |
| AMENDMENT NO. 3 | 2024-11-14 | English | |
| 10-Q | 2024-11-07 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
1 filing
| |||||
| 13314265 | Major Shareholding Notification 2025 | 2025-01-24 | English | ||
|
2024
14 filings
| |||||
| 13314269 | 424B5 | 2024-12-20 | English | ||
| 13314266 | 8-K | 2024-12-20 | English | ||
| 13314267 | 8-K | 2024-12-20 | English | ||
| 13314268 | AMENDMENT NO. 3 | 2024-11-14 | English | ||
| 13314270 | 10-Q | 2024-11-07 | English | ||
| 13314272 | 8-K | 2024-11-07 | English | ||
| 13314273 | AMENDMENT NO. 6 TO SCHEDULE 13D | 2024-10-02 | English | ||
| 13314274 | 8-K | 2024-09-23 | English | ||
| 13314275 | AMENDMENT NO. 5 TO SCHEDULE 13D | 2024-09-06 | English | ||
| 13314276 | 4 | 2024-09-03 | English | ||
| 13314277 | 4 | 2024-09-03 | English | ||
| 13314279 | 10-Q | 2024-08-08 | English | ||
| 13314280 | 8-K | 2024-08-08 | English | ||
| 13314281 | Major Shareholding Notification 2024 | 2024-08-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
BioAtla, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34681/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34681 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34681 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34681 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34681}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BioAtla, Inc. (id: 34681)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.